Literature DB >> 7903385

Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium.

C S Bockman1, W B Jeffries, P W Abel.   

Abstract

Alpha-2 adrenergic receptor subtypes were characterized in membranes of pig vascular endothelium using [3H]rauwolscine. Alpha-2 adrenergic receptor subtypes that mediate endothelium-dependent vascular relaxation were studied in vitro by using ring segments of pig epicardial coronary arteries. Specific [3H]rauwolscine binding in endothelial membranes was saturable and to a single class of high-affinity sites with a mean KD of 0.217 +/- 0.05 nM and Bmax of 156 +/- 28 fmol/mg of protein. Nonlinear regression analysis indicated that competition binding curves for drugs that distinguish the alpha-2A adrenergic receptor subtype from the alpha-2C adrenergic receptor subtype fit best to two-site binding models. Kl values for drugs in binding to endothelial alpha-2 adrenergic receptors correlated well with their Kl values for alpha-2A (r = .98) and alpha-2C (r = .97) adrenergic receptor subtypes identified in other tissues. Vascular endothelium contained 23% alpha-2A and 77% alpha-2C adrenergic receptors. In the presence of indomethacin, the rank order of potency for agonists that cause endothelium-dependent vascular relaxation was p-iodoclonidine > clonidine > UK-14,304 > guanabenz > epinephrine > norepinephrine. KB values for antagonist inhibition of epinephrine-induced, endothelium-dependent vascular relaxation correlated best with Kl values for antagonist binding at the alpha-2A adrenergic receptor subtype. These results suggest that the alpha-2A and alpha-2C adrenergic receptor subtypes are present on pig vascular endothelium and that the alpha-2A adrenergic receptor subtype mediates indomethacin-insensitive, endothelium-dependent relaxation of pig epicardial coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903385

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery.

Authors:  C González; S Regunathan; D J Reis; C Estrada
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

Authors:  X F Figueroa; M I Poblete; M P Boric; V E Mendizábal; E Adler-Graschinsky; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.

Authors:  T Görnemann; H von Wenckstern; B Kleuser; C M Villalón; D Centurión; S Jähnichen; H H Pertz
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

4.  alpha(2)-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: evidence for involvement of the vascular endothelium.

Authors:  R E Roberts; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Acute dilation to alpha(2)-adrenoceptor antagonists uncovers dual constriction and dilation mediated by arterial alpha(2)-adrenoceptors.

Authors:  P A Crassous; S Flavahan; N A Flavahan
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

6.  The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.

Authors:  I K Wright; N A Blaylock; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

7.  Adrenergic mechanism in the control of endothelial function.

Authors:  Daniela Sorriento; Bruno Trimarco; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2011-10-17

8.  Comparative Assessment of Retinal Blood Flow Velocity Changes Following Brimonidine and Brinzolamide Administration Using Retinal Function Imaging.

Authors:  Tim J Enz; Mario Bittner; James R Tribble; Pete A Williams; Michael A Thiel; Martin K Schmid; Lucas M Bachmann; Frank Bochmann
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.